Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The diminished pipeline for medications to treat mental health and substance use disorders.

O'Brien PL, Thomas CP, Hodgkin D, Levit KR, Mark TL.

Psychiatr Serv. 2014 Dec 1;65(12):1433-8. doi: 10.1176/appi.ps.201400044. Epub 2014 Nov 17.

2.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
3.

Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities.

Fisher JA, Cottingham MD, Kalbaugh CA.

Soc Sci Med. 2015 Apr;131:322-30. doi: 10.1016/j.socscimed.2014.08.023. Epub 2014 Aug 19.

4.

Revitalizing psychiatric drug discovery.

Sarter M, Tricklebank M.

Nat Rev Drug Discov. 2012 Jun 1;11(6):423-4. doi: 10.1038/nrd3755.

PMID:
22653200
5.

Mental health policy and psychotropic drugs.

Frank RG, Conti RM, Goldman HH.

Milbank Q. 2005;83(2):271-98. Review.

6.

Psychiatric drug discovery on the couch.

[No authors listed]

Nat Rev Drug Discov. 2007 Mar;6(3):171. doi: 10.1038/nrd2268.

PMID:
17396285
7.

Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.

Kato TA, Yamauchi Y, Horikawa H, Monji A, Mizoguchi Y, Seki Y, Hayakawa K, Utsumi H, Kanba S.

Curr Med Chem. 2013;20(3):331-44. Review.

PMID:
23157624
8.

Pharmacogenetics of psychotropic drug response.

Malhotra AK, Murphy GM Jr, Kennedy JL.

Am J Psychiatry. 2004 May;161(5):780-96. Review.

PMID:
15121641
9.

What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?

Becker RE, Seeman MV, Greig NH, Lahiri DK.

Lancet Psychiatry. 2015 Aug;2(8):756-764. doi: 10.1016/S2215-0366(15)00214-X. Review.

10.

Psychotropic medication use in children and adolescents in an inpatient setting.

Pejovic-Milovancevic M, Miletic V, Popovic-Deusic S, Draganic-Gajic S, Lecic-Tosevski D, Marotic V.

Psychiatriki. 2011 Oct-Dec;22(4):314-9.

PMID:
22271844
11.

Psychotropic drugs and paediatrics: a critical need for more clinical trials.

Tishler CL, Reiss NS.

J Med Ethics. 2012 Apr;38(4):250-2. doi: 10.1136/medethics-2011-100003. Epub 2011 Nov 2. Review.

PMID:
22048850
12.

Managing psychotropic drug costs: will formularies work?

Huskamp HA.

Health Aff (Millwood). 2003 Sep-Oct;22(5):84-96.

13.

[Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study].

Gasquet I, Nègre-Pagès L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lépine JP.

Encephale. 2005 Mar-Apr;31(2):195-206. French.

PMID:
15959446
14.

Challenges and opportunities in bringing new medications to market for pediatric patients.

Upadhyaya HP, Gault L, Allen AJ.

J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1056-9. doi: 10.1097/CHI.0b013e3181baec67. No abstract available.

PMID:
19855220
15.

Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study.

Himelhoch S, Josephs JS, Chander G, Korthuis PT, Gebo KA; HIV Research Network.

Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):538-45. doi: 10.1016/j.genhosppsych.2009.05.009. Epub 2009 Aug 27.

16.

Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection.

Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig SC, Weissbecker H, Kepplinger HM, Sobota K.

J Nerv Ment Dis. 1997 Mar;185(3):151-8.

PMID:
9091596
17.

[Clinically significant interactions of psychotropic drugs used in psychiatry].

Szymura-Oleksiak J.

Pol Merkur Lekarski. 2000 Sep;9(51):627-9. Review. Polish.

PMID:
11126992
18.

[Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].

Grolleau A, Cougnard A, Bégaud B, Verdoux H.

Encephale. 2008 Sep;34(4):352-9. doi: 10.1016/j.encep.2007.07.011. Epub 2007 Dec 26. French.

PMID:
18922237
19.

Three paths to drug discovery in psychiatry.

Berk M, Nierenberg AA.

Am J Psychiatry. 2015 May;172(5):412-4. doi: 10.1176/appi.ajp.2014.14070858. No abstract available.

PMID:
25930130
20.

Epidemiology of psychotropic drug use in Rio de Janeiro, Brazil: gaps in mental illness treatments.

Quintana MI, Andreoli SB, Moreira FG, Ribeiro WS, Feijo MM, Bressan RA, Coutinho ES, Mari JJ.

PLoS One. 2013 May 14;8(5):e62270. doi: 10.1371/journal.pone.0062270. Print 2013.

Supplemental Content

Support Center